DrugPatentWatch Database Preview
« Back to Dashboard
Homatropine methylbromide; hydrocodone bitartrateis the generic ingredient in five branded drugs marketed by Genus Lifesciences, Abhai Llc, Actavis Mid Atlantic, Hi Tech Pharma, Ivax Sub Teva Pharms, Novel Labs Inc, Paddock Llc, Torrent, Wockhardt Bio Ag, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.
There are five drug master file entries for homatropine methylbromide; hydrocodone bitartrate. Thirteen suppliers are listed for this compound.
Summary for homatropine methylbromide; hydrocodone bitartrate
|Drug Master File Entries:||5|
|Suppliers / Packagers:||13|
|DailyMed Link:||homatropine methylbromide; hydrocodone bitartrate at DailyMed|
Pharmacology for homatropine methylbromide; hydrocodone bitartrate
|Drug Class||Opioid Agonist |
Cholinergic Muscarinic Agonist
|Mechanism of Action||Opioid Agonists |
Cholinergic Muscarinic Agonists
Make Better Decisions: Try a trial or see plans & pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.